English (US)
Our business
Our advances cutting-edge biotechnology across four key areas: translating health and longevity research into practical applications, precision human assessment through biological pathway analysis and multi-omics, AI-powered biomedical applications, and gene therapy pipeline development. Our ambition is to help shape the future of biomedicine by addressing some of the most pressing challenges in aging and disease.
Translating Cutting-Edge Health and Longevity Science into Practice
We bring together advanced technologies from leading research institutions worldwide to explore health and aging interventions. Guided by three core biological pathways—gene regulation, metabolism, and signal transduction—we translate cutting-edge research into health solutions designed to be measurable, assessable, and continuously refined.
Learn More ›
Advanced Multi-Omics Platform for Biological Pathway Analysis and Human Assessment
Building on the 14 hallmarks of aging described in Cell, our platform applies pathway-focused multi-omics technologies to analyze a broad range of biomarkers, including genes, proteins, metabolites, and indicators associated with key biological pathways. This integrated approach enables a comprehensive assessment of human health and aging, delivering detailed, data-driven insights and supporting personalized aging assessments and intervention strategies.
Learn More ›
AI-Powered Biomedical Applications Platform
By leveraging advanced AI models, algorithms, and bioinformatics, we aim to significantly enhance R&D efficiency. Drawing on the scientific thinking and expertise of leading researchers worldwide, we are developing an AI-powered health intelligence platform designed to deliver expert-level insights.
Learn More ›
Gene Therapy Pipeline
Focusing on frontier areas such as gene editing, cellular reprogramming, and immunotherapy, we advance early-stage program initiation and validation of technical approaches.
Learn More ›